Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Annals of the Rheumatic Diseases|September 15, 2021
From sequential to combination and personalised therapy in lupus nephritis: moving towards a paradigm shift?Ioannis Parodis, Frederic A Houssiau
Lupus|September 17, 2025
Obesity is an independent poor prognostic factor in lupus nephritisFrancy Cuervo, Antoine Enfrein, Hans-Joachim Anders, et al.
Annals of the Rheumatic Diseases|February 11, 2022
Phase II randomised trial of type I interferon inhibitor anifrolumab in patients with active lupus nephritisDavid Jayne, Brad Rovin, Eduardo F Mysler, et al.
Annals of the Rheumatic Diseases|December 25, 2019
IFN-α kinoid in systemic lupus erythematosus: results from a phase IIb, randomised, placebo-controlled studyFrederic A Houssiau, Aikaterini Thanou, Minodora Mazur, et al.
Annals of the Rheumatic Diseases|June 24, 2021
Quality indicators for systemic lupus erythematosus based on the 2019 EULAR recommendations: development and initial validation in a cohort of 220 patientsKaterina Chavatza, Myrto Kostopoulou, Dionysis Nikolopoulos, et al.
Kidney International Reports|January 16, 2026
A Pooled Analysis of Sex Differences in Lupus NephritisKristina K Nasr, Ryan B Coopergard, Sisi Ma, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|September 19, 2018
Establishing Surrogate Kidney End Points for Lupus Nephritis Clinical Trials: Development and Validation of a Novel Approach to Predict Future Kidney OutcomesMeggan Mackay, Maria Dall'Era, Joanna Fishbein, et al.
Pageof 2